Document is current

Article History

Received: 27 October 2025

Accepted: 5 December 2025

First Online: 27 December 2025

Declarations

:

: Alejandro Molina-Levya is an Editorial Board member of Dermatology and Therapy . Alejandro Molina-Levya was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Alejandro Molina-Leyva has received support for attending meetings, served as an advisory board member and participated in clinical trials from Abbvie, Novartis, Moonlake, MSD, Sanofi, Incyte Almirall and UCB. Carmen García-Moronta, Francisco Javier León-Pérez, Alberto Soto-Moreno, Julia Castro-Martín received support from UCB and Novartis to attend scientific congresses. Salvador Arias-Santiago declares no conflicts of interest related to the content of this publication.

: This study received approval from the Provincial Research Ethics Committee of Granada (CEIm Provincial de Granada) under reference code SICEIA-2025-001696. All procedures were conducted in accordance with the principles of the Declaration of Helsinki. Given the retrospective design, the requirement for informed consent was waived by the committee. Patient confidentiality was strictly protected, with all data anonymised prior to analysis and no identifiable information retained.